SCHEMBL1753887

SCHEMBL1753887

CC(=O)C(C(C)=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.55
TP53 P04637 1/20 0.55
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
SRD5A2 P31213 4/20 0.48
ANPEP P15144 1/20 0.47
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA12 O43570 1/20 0.46
CA3 P07451 1/20 0.46
TYR P14679 1/20 0.46
DRD1 P21728 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
KMT2A Q03164 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7680641 0.91 TSHR (0.50) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL1753679 0.90 TSHR (0.48) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL11458883 0.85 BRD4 (0.44) TSHRALDH1A1HPGD
SCHEMBL10936588 0.80 TSHR (0.52) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL5374859 0.80 ANPEP (0.55) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL1312762 0.78 SRC (0.64) ALDH1A1KMT2AHPGDALOX15TDP1
Terephthalic Acid SCHEMBL123278 0.77 TSHR (0.80) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
Terephthalic Acid SCHEMBL8209798 0.77 TSHR (0.80) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
Terephthalic Acid SCHEMBL28358071 0.77 TSHR (0.80) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL11012611 0.76 SRC (0.61) ALDH1A1KMT2AHPGDALOX15TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 TSHR 1838/4885TP53 1553/4885ALDH1A1 784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.